Home/Bills/HB 388Ohio · 136th General Assembly (2025–2026)

House BillIntroduced

HB 388: Regards state employee reimbursement for GLP-1 drug costs

Ohio · House · 136th General Assembly (2025–2026) · last verified June 2, 2026

What HB 388 does, verified June 2, 2026

The bill provides reimbursements to state employees and elected state officials for out-of-pocket costs of purchasing a specific type of diabetes medication, known as a glucagon-like peptide-1 (GLP-1) drug. This medication is approved for chronic weight management and must be purchased through a manufacturer's direct-to-consumer program or a participating pharmacy. The reimbursements are subject to certain conditions, including a 24-month waiting period and a limit on the amount reimbursed per month. The waiting period begins in the month the employee or official first applies for a reimbursement, and the reimbursement amount is capped at $500 for the first year and $250 for subsequent years. Additionally, employees and officials must meet certain eligibility requirements, including a body mass index (BMI) of at least 30 and proof of out-of-pocket costs. The bill also allows officials t…

Bill journey

1IntroducedCurrent

2In CommitteePending

3First Chamber FloorPending

4Second ChamberPending

5GovernorPending

6ChapteredPending

Last action: Referred to committee: General Government (2025-09-15)Alert me

Author and sponsors

Rep. Josh WilliamsAuthor · Ohio House of Representatives

Full contact details, staff, and committees with Connect, $16/moUnlock

Recent actions2 total · showing 2

Sep. 15, 2025	Referred to committee: General Government
Jul. 01, 2025	Introduced

Latest bill textIntroduced version, July 1, 2025 · 886 words

As Introduced

136th General Assembly

Regular Session

H. B. No. 388

2025-2026

Representatives Williams, Jarrells

To enact section 124.826 of the Revised Code regarding reimbursements to state employees and elected state officials for GLP-1 drug costs.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section 1. That section 124.826 of the Revised Code be enacted to read as follows:

Sec. 124.826.

(A) As used in this section:

(1)

"GLP-1 drug" means a drug included within the class of drugs known as glucagon-like peptide-1 receptor agonists.

(2)

"Pharmacy" has the same meaning as in section 4729.01 of the Revised Code.

(3)

"Physician" means an individual authorized under Chapter 4731. of the Revised Code to practice medicine and surgery or osteopathic medicine and surgery.

(B) Notwithstanding section 3901.71 of the Revised Code or any other provision of the Revised Code to the contrary, and subject to divisions (C), (D), and (E) of this section, beginning on the effective date of this section, the health care benefits provided under section 124.82 of the Revised Code shall include reimbursements to cover out-of-pocket costs that a state employee or elected state official pays to purchase a supply of a GLP-1 drug that meets all of the following conditions:

(1)

The drug is approved by the federal food and drug administration for chronic weight management.

(2)

The drug is purchased from a manufacturer's direct-to-consumer program or through a pharmacy or other entity participating in a manufacturer's direct-to-consumer program.

(3)

The drug is not a compounded version of a GLP-1 drug.

(C) Except as provided in division (F) of this section, no employee or official may apply to receive a reimbursement under this section for a period exceeding twenty-four consecutive months. The twenty-four-month period during which an employee or official may apply begins in the month in which the employee or official first applies for a reimbursement under this section. No reimbursement shall exceed either of the amounts described under division (E) of this section.

(D) For each month in which an employee or official pays out of pocket to purchase a supply of a GLP-1 drug described under division (B) of this section, the employee or official may apply to the director of administrative services for a reimbursement. The employee or official shall include in the reimbursement application both of the following:

(1)

Proof that, at the time treatment is initiated, the employee's or official's body mass index is at least thirty, as determined by a physician;

(2)

The amount that the employee or official paid out of pocket to purchase a supply of a GLP-1 drug described under division (B) of this section.

(E)

(1)

An employee or official whom the director determines is eligible for a reimbursement under this section shall be reimbursed in either of the following amounts:

(a)

For any month of the first year during which the employee or official is eligible for reimbursement, not more than five hundred dollars;

(b)

For any month of the second year during which the employee or official is eligible for reimbursement, an amount equal to one-half of the cost the employee or official paid out of pocket to purchase a supply of a GLP-1 drug described under division (B) of this section, not to exceed two hundred fifty dollars.

(2)

If the director determines that an employee or official is not eligible for a reimbursement in any month, the employee or official shall not receive a reimbursement for that month. An employee or official whom the director determines is not eligible for a reimbursement in any month during the twenty-four-month period described under division (C) or (F) (2) of this section is not precluded from applying for a reimbursement in any subsequent month during that period.

(F)

(1)

Not earlier than six months after the previous twenty-four-month period during which an employee or official applies for reimbursements under this section elapses, the employee or official may apply to the director to seek reimbursements under this section for a subsequent period not exceeding twenty-four consecutive months. The employee or official shall include in the application proof that, at the time of application, the employee's or official's weight has increased by at least twenty per cent of the total amount of weight the employee or official lost during the previous twenty-four-month period, measured as of the last day of that period.

(2)

If the director determines the employee's or official's weight has increased by the amount specified under division (F) (1) of this section, the director shall approve the employee's or official's application. An employee or official whose application is approved may apply for reimbursements under this section for a subsequent twenty-four-month period.

(3)

If the director determines the employee's or official's weight has not increased by the amount specified under division (F) (1) of this section, the director shall not approve the employee's or official's application.

(G) The director shall adopt rules in accordance with Chapter 119. of the Revised Code to implement this section.

Text of HB 388 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions